Abstract
Patients taking antiepileptic medications may require plasma exchange (PEX) for treatment of an unrelated condition. We studied total serum levels of carbamazepine (CBZ) serially, before and after five PEX cycles, in an epilepsy patient who underwent PEX for myasthenia gravis. A small but consistent reduction in the CBZ levels was noted immediately after each cycle, and a gradual and cumulative increase in the serum levels was observed over the duration of the PEX cycles. We conclude that alterations in the serum CBZ levels with PEX are not clinically significant to merit adjustment of the CBZ dose.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
